Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Serum Prolactin Levels Among Outpatients With Major Depressive Disorder During the Acute Phase of Treatment With Fluoxetine PDF $40.00
$40.00
× Placeholder Safety of Mirtazapine in Overdose PDF $40.00
$40.00
× Placeholder History of Attempted Suicide and Reckless Driving: A Cross-Sectional Study in Primary Care PDF $40.00
$40.00
× Placeholder Early Response to Ketamine for Suicidal Crisis Reduces Suicidal Events at 3 Months PDF $40.00
$40.00
× Placeholder Major Depressive Disorder and Borderline Personality Disorder Revisited: Longitudinal Interactions PDF $40.00
$40.00
× Placeholder Efficacy, Adverse Events, and Treatment Discontinuations in Fluoxetine Clinical Studies of Major Depression: A Meta-Analysis of the 20-mg/day Dose PDF $40.00
$40.00
× Placeholder Group Therapy for Patients With Bipolar Disorder and Substance Dependence: Results of a Pilot Study PDF $40.00
$40.00
× Placeholder An Open Trial of Behavioral Activation in Veterans With Major Depressive Disorder or Posttraumatic Stress Disorder in Primary Care PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $320.00
Total $320.00
Proceed to checkout

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe